Search research articles
Contact Us
Filters
Showing results (51-60 of 155) with videos related to
Page
of 16
Sort By:
Journal of Medicinal Chemistry
|
March 5, 2004
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies
Rino Ragno, Antonello Mai, Silvio Massa, et al.
Retrovirology
|
June 3, 2009
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
Andrea Savarino, Antonello Mai, Sandro Norelli, et al.
Journal of Molecular Cell Biology
|
March 13, 2014
Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity
Annalisa Zecchin, Lucia Pattarini, Maria Ines Gutierrez, et al.
Plos One
|
February 6, 2013
Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29
Inge Mannaerts, Nathalie Eysackers, Oscar O Onyema, et al.
Frontiers in Pharmacology
|
September 9, 2020
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas
Matteo Cassandri, Rossella Fioravanti, Silvia Pomella, et al.
ACS Chemical Biology
|
September 1, 2015
Discovery of Inhibitors for the Ether Lipid-Generating Enzyme AGPS as Anti-Cancer Agents
Valentina Piano, Daniel I Benjamin, Sergio Valente, et al.
The International Journal of Biochemistry & Cell Biology
|
October 7, 2008
New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations
Antonello Mai, Sergio Valente, Angela Nebbioso, et al.
Journal of Computer-Aided Molecular Design
|
April 6, 2026
Combined computational and classical medicinal chemistry procedure to disclose novel pyrrole-based compounds as potential antituberculosis agents
Rino Ragno, Clemens Zwergel, Sergio Valente, et al.
Redox Biology
|
February 28, 2020
A closer look into NADPH oxidase inhibitors: Validation and insight into their mechanism of action
Joana Reis, Marta Massari, Sara Marchese, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
December 31, 2013
Chalcone-Coumarin derivatives as potential anti-cancer drugs: an in vitro and in vivo investigation
Vincent Jamier, Wioleta Marut, Sergio Valente, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 155) with videos related to
Sort By:
Page
of 16
Journal of Medicinal Chemistry
|
March 5, 2004
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies
Rino Ragno, Antonello Mai, Silvio Massa, et al.
Retrovirology
|
June 3, 2009
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
Andrea Savarino, Antonello Mai, Sandro Norelli, et al.
Journal of Molecular Cell Biology
|
March 13, 2014
Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity
Annalisa Zecchin, Lucia Pattarini, Maria Ines Gutierrez, et al.
Plos One
|
February 6, 2013
Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29
Inge Mannaerts, Nathalie Eysackers, Oscar O Onyema, et al.
Frontiers in Pharmacology
|
September 9, 2020
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas
Matteo Cassandri, Rossella Fioravanti, Silvia Pomella, et al.
ACS Chemical Biology
|
September 1, 2015
Discovery of Inhibitors for the Ether Lipid-Generating Enzyme AGPS as Anti-Cancer Agents
Valentina Piano, Daniel I Benjamin, Sergio Valente, et al.
The International Journal of Biochemistry & Cell Biology
|
October 7, 2008
New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations
Antonello Mai, Sergio Valente, Angela Nebbioso, et al.
Journal of Computer-Aided Molecular Design
|
April 6, 2026
Combined computational and classical medicinal chemistry procedure to disclose novel pyrrole-based compounds as potential antituberculosis agents
Rino Ragno, Clemens Zwergel, Sergio Valente, et al.
Redox Biology
|
February 28, 2020
A closer look into NADPH oxidase inhibitors: Validation and insight into their mechanism of action
Joana Reis, Marta Massari, Sara Marchese, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
December 31, 2013
Chalcone-Coumarin derivatives as potential anti-cancer drugs: an in vitro and in vivo investigation
Vincent Jamier, Wioleta Marut, Sergio Valente, et al.
Page
of 16